期刊
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
卷 20, 期 1, 页码 34-53出版社
BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527319666200916121515
关键词
Nanotechnology; nanoparticles; neurodegenerative disease; Alzheimer's disease; Parkinson's disease; Huntington's disease
Neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's disease have a significant impact on quality of life, but current treatment strategies often face limitations in crossing the Blood-Brain Barrier. Nanotechnology shows promise in addressing these challenges over the past 20 years.
Neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据